Solaris

SOLARIS BY XENO LABORATORIES

Injectable Oily Solution

DRUG COMPOSITION

1 mL of solution contains:
 - active substance: clenbuterol hcl, yohimbine hcl 5.4 mg;
 - auxiliary substances:

DRUG DESCRIPTION

Transparent oily solution, from yellow to light yellow color, with characteristic smell.

PHARMACEUTICAL FORM

Injectable oily solution.

PHARMACEUTICAL GROUP AND ATC CODE

Beta-2 Agonist.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: N/A
Routes of administration: intramuscular injection
Dosage forms: (Men): N/A; (Women): -
Acne: n/a
Water retention: n/a
High blood pressure: n/a
Hepatotoxicity: n/a
Aromatase: n/a
Decreased HPTA function (own testosterone production): n/a
Anabolic activity: N/A
Androgenic activity: N/A
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

Injectable oily solution 5.4 mg / 1 mL in 10 mL Vial vials.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Xeno Laboratories
USA